TELA Bio
NASDAQ: TELAMalvern, US · Founded 2012 · Delaware corporation · 5 known investors
Founders & leadership
VB
Vince BurgassDirector
KR
Kevin RakinDirector
AF
Ashley FreidmanDirector
FC
Francis ConwayExecutive Officer
MP
Maarten PersenaireExecutive Officer
AK
Antony KoblishExecutive Officer, Director
PT
Paul TouheyDirector
AO
Adele OlivaDirector
Investors · 5
Reported raises · per SEC filings
Form D private placements▶$10.6MraisedJul 2019 · 15 investors · BiotechnologyRule 506(b)
▶$10.6MraisedJul 2019 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Antony KoblishExecutive Officer, Director
- Ashley FriedmanDirector
- Matt ZugaDirector
- Kurt AzarbarzinDirector
- Nora BrennanExecutive Officer
- Adele OlivaDirector
- Maarten PersenaireExecutive Officer
- Francis ConwayExecutive Officer
- Ronald J. Ellis, Jr.Director
- Vince BurgessDirector
- Offering amount
- $20M
- Amount sold
- $10.6M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.1MraisedDec 2018 · 8 investors · BiotechnologyRule 506(b)
▶$2.1MraisedDec 2018 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Adele OlivaDirector
- Francis ConwayExecutive Officer
- Kevin RakinDirector
- Ronald J. Ellis, Jr.Director
- Antony KoblishExecutive Officer, Director
- Maarten PersenaireExecutive Officer
- Kurt ArarbarzinDirector
- Ashley FriedmanDirector
- Vince BurgessDirector
- Offering amount
- $3.5M
- Amount sold
- $2.1M
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$501.1KraisedMay 2018 · 1 investors · BiotechnologyRule 506(b)
▶$501.1KraisedMay 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Adele OlivaDirector
- Maarten PersenaireExecutive Officer
- Antony KoblishExecutive Officer, Director
- Kevin RakinDirector
- Francis ConwayExecutive Officer
- Ronald J. Ellis Jr.Director
- Ashley FriedmanDirector
- Vince BurgessDirector
- Christopher SmithExecutive Officer
- Paul TouheyDirector
- Offering amount
- $2M
- Amount sold
- $501.1K
- Minimum investment
- $250K
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$240KraisedMay 2018 · 1 investors · BiotechnologyRule 506(b)
▶$240KraisedMay 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Antony KoblishExecutive Officer, Director
- Ronald J. Ellis, Jr.Director
- Paul TouheyDirector
- Ashley FriedmanDirector
- Maarten PersenaireExecutive Officer
- Francis ConwayExecutive Officer
- Vince BurgessDirector
- Christoper SmithExecutive Officer
- Adele OlivaDirector
- Kevin RakinDirector
- Offering amount
- $240K
- Amount sold
- $240K
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedApr 2018 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedApr 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Antony KoblishExecutive Officer, Director
- Ronald J. Ellis, Jr.Director
- Paul TouheyDirector
- Adele OlivaDirector
- Ashley FriedmanDirector
- Christopher SmithExecutive Officer
- Kevin RakinDirector
- Maarten PersenaireExecutive Officer
- Vince BurgessDirector
- Francis ConwayExecutive Officer
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedApr 2018 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedApr 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Maarten PersenaireExecutive Officer
- Christopher SmithExecutive Officer
- Ashley FriedmanDirector
- Ronald J. Ellis, Jr.Director
- Francis ConwayExecutive Officer
- Kevin RakinDirector
- Paul TouheyDirector
- Adele OlivaDirector
- Antony KoblishExecutive Officer, Director
- Vince BurgessDirector
- Offering amount
- $1M
- Amount sold
- $500K
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15MraisedNov 2017 · 1 investors · BiotechnologyRule 506(b)
▶$15MraisedNov 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Antony KoblishExecutive Officer, Director
- Kevin RakinDirector
- Christopher SmithExecutive Officer
- Paul TouheyDirector
- Francis ConwayExecutive Officer
- Adele OlivaDirector
- Maarten PersenaireExecutive Officer
- Vince BurgessDirector
- Ashley FriedmanDirector
- Offering amount
- $25M
- Amount sold
- $15M
- First sale
- Oct 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.4MraisedJan 2017 · 16 investors · BiotechnologyRule 506(b)
▶$7.4MraisedJan 2017 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Vince BurgassDirector
- Kevin RakinDirector
- Ashley FreidmanDirector
- Francis ConwayExecutive Officer
- Maarten PersenaireExecutive Officer
- Antony KoblishExecutive Officer, Director
- Paul TouheyDirector
- Adele OlivaDirector
- Offering amount
- $7.5M
- Amount sold
- $7.4M
- Minimum investment
- $50K
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.